- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Erectile Dysfunction With Type 1 Diabetes Mellitus in United States
Total 4578 results
-
University of New MexicoRecruitingObesity | PreDiabetes | Type 2 Diabetes | Ketogenic DietingUnited States
-
The University of Texas Health Science Center at...National Institute on Aging (NIA); The Claude D. Pepper Older Americans Independence...CompletedType 2 Diabetes | Frailty | Weight, BodyUnited States
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Denmark, France, Ireland, Korea, Republic of, Portugal, United Kingdom
-
GlaxoSmithKlineCompleted
-
AstraZenecaCompletedDiabetes Mellitus, Type 2United States
-
Elixir PharmaceuticalsCompletedDiabetes Mellitus, Type 2United States, Puerto Rico
-
University of RochesterCompletedObesity | Diabetes Mellitus, Type 2 | Insulin Resistance | Nutritional and Metabolic DiseaseUnited States
-
University of ArkansasCompletedDiabetes Mellitus, Type 2 | CirrhosisUnited States
-
Medical College of WisconsinRecruitingType 2 DiabetesUnited States
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Canada, Greece, India, Philippines, Thailand, Ukraine
-
University of PittsburghCompletedDiabetes Mellitus, Type 2 | InsomniaUnited States
-
Palo Alto Medical FoundationCompletedObesity | Cardiovascular Disease | Metabolic Syndrome | Type 2 Diabetes | Pre-diabetesUnited States
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Poland, Russian Federation, United Kingdom, France, Ukraine
-
Anji PharmaSuspendedDiabetes Mellitus, Type 2Spain, United States, Canada, Hungary, Brazil, Czechia, Poland, Bulgaria
-
PfizerCompletedDiabetes Mellitus, Type 2United States, Hungary, Taiwan, Bulgaria, Canada, Korea, Republic of, Poland, Slovakia
-
SanofiTerminatedSleep Initiation and Maintenance DisordersUnited States, Canada, Brazil, Russian Federation, Australia, Germany, Italy, Spain, Turkey, India, Malaysia, Singapore, Belgium, Czech Republic, Mexico, Argentina, Austria, Colombia, Chile, South Africa, United Kingdom, Hong Kong
-
AstraZenecaTerminatedDiabetes Mellitus, Type 2United States
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2United States, Austria, Croatia, Czech Republic, Estonia, Finland, France, Germany, Hungary, Italy, Korea, Republic of, Latvia, Lithuania, Norway, Romania, Russian Federation, Slovakia, Spain, Sweden, Taiwan, Ukraine
-
Matthew GroutCompletedDiabetes Mellitus, Type 2 | Cognitive ImpairmentUnited Kingdom
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Puerto Rico, Russian Federation, Canada, Denmark, India, Poland, Korea, Republic of, Brazil, Argentina, Mexico, South Africa
-
AstraZenecaTerminatedDiabetes Mellitus, Type 2United States, Spain, United Kingdom, Germany, Finland, Norway, Israel, Netherlands
-
SanofiCompletedDiabetes Mellitus, Type 2Brazil, United States, Finland, Spain, Austria, Canada, Czech Republic, France, Greece, Ireland, Israel, Mexico, Netherlands, Russian Federation, Slovakia, Sweden, Turkey
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2United States, Czech Republic, Finland, Greece, India, Israel, Mexico, New Zealand, Russian Federation, Sweden
-
PfizerCompletedDiabetes Mellitus, Type 2Canada, United States, Korea, Republic of, Puerto Rico
-
Newcastle-upon-Tyne Hospitals NHS TrustBritish Heart Foundation; University of Newcastle Upon-TyneCompletedType 2 Diabetes Mellitus | Acute Coronary SyndromeUnited Kingdom
-
Janssen Research & Development, LLCCompletedDiabetes Mellitus, Type 2United States, Colombia, Mexico, Poland, Spain, India, Malaysia, Romania, South Africa, Sweden, Korea, Republic of, Estonia, Puerto Rico, Austria, Lithuania, Philippines, Guatemala, Iceland
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Puerto Rico, Poland, Canada, Austria, Mexico, Denmark, Croatia, Brazil, Argentina, Romania, South Africa, Russian Federation, France, Lithuania
-
GlaxoSmithKlineCompletedNon-Insulin-Dependent Diabetes MellitusSpain, Germany, Belgium, United Kingdom, Ireland, Netherlands, Italy, France, Mexico, Switzerland, Lithuania
-
AstraZenecaTerminatedDiabetes Mellitus, Type 2United States, Brazil, United Kingdom, Finland, Argentina, Canada, Mexico
-
University of MiamiWithdrawn
-
PfizerCompletedDiabetes Mellitus, Type 2United States, Colombia, Spain, Germany, Sweden, Italy
-
Children's Hospital Medical Center, CincinnatiChildren's Hospital ColoradoRecruitingDiabetes Mellitus, Type 2 | Pediatric Obesity | Bariatric Surgery CandidateUnited States
-
SanofiCompletedDiabetes Mellitus, Type 2Israel, Czechia, Greece, Italy, United States, Bulgaria, Croatia, Denmark, France, Hungary, Romania, Serbia, Slovakia, Sweden, Switzerland, United Kingdom
-
University of North Carolina, Chapel HillMassachusetts General Hospital; National Institute of Diabetes and Digestive... and other collaboratorsRecruitingHIV Infections | Diabetes Mellitus, Type 2 | PreDiabetesUnited States
-
US Department of Veterans AffairsCompletedDiabetes Mellitus, Type 2 | Intermittent ClaudicationUnited States
-
Intarcia TherapeuticsTerminatedDiabetes Mellitus, Type 2United States, Canada
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Australia, Brazil, Canada, El Salvador, France, Korea, Republic of, New Zealand, Norway, Spain, Taiwan
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Argentina, Brazil, Puerto Rico, Canada, India, Denmark, Czech Republic
-
University of PittsburghUPMC Center for High-Value Health Care; Western Psychiatric Institute and Clinic... and other collaboratorsCompletedVascular Diseases | Cardiovascular Disease | Chronic Disease | Diabetes Mellitus Type 2 | Mental Health | Substance-related Disorders | Behavioral HealthUnited States
-
Pediatric Brain Tumor ConsortiumNational Cancer Institute (NCI); American Lebanese Syrian Associated Charities...RecruitingLow Grade Glioma (LGG) of Brain With BRAF Aberration | High Grade Glioma (HGG) of the Brain With BRAF Aberration | Low Grade Glioma of Brain With Neurofibromatosis Type 1United States
-
SanofiCompletedSleep Initiation and Maintenance DisordersUnited States, France, Canada, Brazil, Russian Federation, Netherlands, Switzerland, Turkey, Malaysia, Taiwan, Czech Republic, Finland, Italy, Colombia, South Africa, Greece
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2United States, Germany, Spain, Canada, Austria, Latvia, Slovakia, United Kingdom, Chile, Mexico, Netherlands
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Estonia, Germany, Latvia, Spain, United Kingdom
-
Janssen Research & Development, LLCCompletedDiabetes Mellitus, Type 2United States, India, China, Brazil, Greece, Malaysia, Mexico, Philippines, Poland, Russian Federation
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2United States, Canada, Australia, Philippines, Mexico, Puerto Rico
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Argentina, Puerto Rico, Mexico
-
RISE Study GroupNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completed
-
University of MinnesotaCompleted
-
PfizerCompletedNon-alcoholic SteatohepatitisUnited States, Canada
-
Imperial College London Diabetes CentreUnknownGestational Diabetes | Maturity-onset Diabetes of the Young | GDM | MODYUnited Arab Emirates